openPR Logo
Press release

North America to continue to lead the anti-epileptic drugs market – GMI Research

12-27-2018 03:29 PM CET | Health & Medicine

Press release from: GMI Research

North America to continue to lead the anti-epileptic drugs market – GMI Research

North America to continue to lead the anti-epileptic drugs market – GMI Research

The global Anti-Epileptic Drugs market was valued at USD 3,323.7 million in 2017 and is projected to reach USD 4,458.1 million by 2025, growing at a CAGR of 3.8% during 2018–2025. The major factors driving the anti-epileptic drugs market is the rising awareness about epilepsy, new drug approvals, and drug structure advancements in Anti-Epileptic Drugs industry are likely to drive the growth of the global Anti-Epileptic Drugs market in near future.

Furthermore, advancements in medication management and healthcare services with the increasing number of drug approvals across the globe have led to the burgeoning market growth of Anti-Epileptic Drugs market.

Request Sample Brochure : https://tinyurl.com/y776x8ar

Valproic Acid drug segment is expected to dominate global Anti-Epileptic Drugs market during the forecast period. In 2017, about one-fourth of the market share was held by Valproic Acid drug in the component segment. However, the highest growth rate is expected to be witnessed by the Lacosamide component segment during the forecast period owing to the increase in usage in the treatment of partial-onset seizures.

“Players are investing a lot in developing and introducing anti-epileptic drugs. For instance, On January 2017, Novartis drug Votubia got approval from EU. This drug will be used for the treatment of refractory partial-onset seizures in patients with TSC. Further, it is foreseen with the growing awareness about the disease and government initiatives the anti-epileptic drugs market will witness significant growth in the emerging markets of Asia-Pacific in the coming 4-5 years .”
—-GMI Research

Based on geography, North America held the largest share in the market in 2017 because of growing awareness about the disease and treatment available, increasing number of rehabs and surgical centers in the region and exponential increase in the epilepsy population. In addition, there has been a rise in the number of approved anti- epileptic drugs. Europe is the second largest region for Anti-Epileptic Drugs market and is expected to grow at a moderate rate during the forecast period.

Buy Report @ https://tinyurl.com/y776x8ar

Key takeaways:
• In 2017, the Valproic Acid drug type held about one-fourth of the market share.
• Abbott Laboratories, Cephalon, Inc, Sunovion Pharmaceuticals, and Valeant Pharmaceuticals are the leading players.
• Lacosamide drug type is anticipated to grow at the highest rate during the forecast period from 2018 to 2025.
• North America region occupied maximum revenue share in the global Anti-Epileptic Drugs market in 2017.

Some of the key players operating in global Anti-Epileptic Drugs market include Abbott Laboratories, Cephalon, Inc, Sunovion Pharmaceuticals, Valeant Pharmaceuticals International, Sanofi S.A, UCB Pharma Ltd, GlaxoSmithKline plc, Johnson & Johnson, Novartis, AG, Pfizer Inc among others.

The global Anti-Epileptic Drugs market has been segmented on the basis of spectrum type, the market comprises of Narrow and Broad Spectrum. The drug type includes Phenytoin, Phenobarbital, Carbamazepine, Oxcarbazepine, Gabapentin, Pregabalin, Lacosamide, Vigabatrin, Valproic Acid, Lamotrigine, Topiramate, Zonisamide, Levetiracetam, Clonazepam, Rufinamide.

The research report “global Anti-Epileptic Drugs market” provides in-depth analysis of the Anti-Epileptic Drugs market, globally, based on spectrum type, drug type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Anti-Epileptic Drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-anti-epileptic-drugs-market-opportunities-forecast-by-spectrum-type-share-trends-industry-report.html

Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America to continue to lead the anti-epileptic drugs market – GMI Research here

News-ID: 1458902 • Views: 557

More Releases from GMI Research

Social Media Analytics Market is estimated to touch USD 21.6 billion in 2029, re …
Social Media Analytics Market was valued at USD 4.2 billion in 2021 and is estimate to reach USD 21.6 billion in 2029 growing at a CAGR of 22.7% For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/social-media-analytics-market-analysis-industry-research/ The factors driving the growth of Social Media Analytics Market includes the increasing demand for business intelligence tools, increasing number of smartphones, growing focus by businesses on collecting customer feedback and proliferation of social
GCC Construction Chemical Market is Predicted to Expand at a Promising CAGR duri …
The GCC Construction Chemical Market is estimated to grow at a robust CAGR over the forecast period (2022-2029). For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/product/gcc-construction-chemical-market/ The factors driving growth of the GCC Construction Chemical Market includes increasing focus of Governments on reducing their dependency on oil and gas sector, emerging need to repair the ageing buildings, rise in the number of smart cities and improvements in the living standards.
5G Industrial IoT Market is projected to touch USD 5,312 million in 2029, regist …
5G Industrial IoT Market was valued at USD 780 million in 2021 and is projected to grow at a CAGR of 27.1% during the forecast period, 2022-2029 reaching USD 5,312 million in 2029 For Additional Insights, Click to Access Complete Report: https://www.gmiresearch.com/report/5g-industrial-iot-market/ Expansion in the 5G industrial IoT market is attributed to the increasing investment in 5G technology and transportation. Also, as per the 5G Industrial IOT Market research report the increasing
North America 3D Printing Market is predicted to increase at a higher CAGR durin …
The North America 3D Printing Market is estimated to grow at a robust CAGR over the forecast period (2022-2029). For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/product/north-america-3d-printing-market/ The factors driving growth of the North America 3D Printing Market includes increasing demand for 3D printing across end-use industries such as Healthcare, Consumer Products and Automotive, growing demand for jewelry across United States and Canada, rise in the number of smart factories,

All 5 Releases


More Releases for Drugs

Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.